Skip to main content

Table 1 Categorical arrangements for the different cell types in 160 rectal cancer patients.

From: Local and distant recurrences in rectal cancer patients are predicted by the nonspecific immune response; specific immune response has only a systemic effect - a histopathological and immunohistochemical study

cell type (antibody)

intratumoral

peritumoral

  

cells / mm2

 

% of patients

cells / mm2

 

% of patients

eosinophils

(EG-2)

 

n = 159

  

n = 140

 
 

none/few

0-10

 

29

0-50

 

31

 

moderate

11-50

 

50

51 - 200

 

43

 

many

> 50

 

21

> 200

 

26

neutrophils

(elastase)

 

n = 160

  

n = 152

 
 

none/few

0-5

 

21

0 - 75

 

24

 

moderate

6 - 50

 

54

   
 

many

> 50

 

25

> 75

 

76

mast cells

(tryptase)

 

n= 160

  

n = 151

 
 

none/few

0 -5

 

19

0-30

 

25

 

moderate

6 -50

 

52

31 -100

 

59

 

many

> 50

 

29

> 100

 

16

macrophages

(CD68)

 

n = 159

    
 

none/few

0-50

 

28

   
 

moderate

51 -150

 

50

   
 

many

> 150

 

22

   

NK cells

(CD56)

 

n = 159

  

n = 136

 
 

none

0

 

33

0

 

43

 

moderate/many

> 0

 

67

> 0

 

57

T cells

(CD3)

 

n = 158

  

n = 157

 
 

none/few

0-55

 

27

0-300

 

20

 

moderate

56-105

 

36

301 - 500

 

51

 

many

>105

 

37

> 500

 

29

CD4+ cells

  

n = 156

  

n = 130

 
 

none/few

0-30

 

43

0-20

 

24

 

moderate

31 -65

 

26

21 -110

 

50

 

many

>65

 

31

> 110

 

26

CD8+ cells

  

n = 159

  

n = 122

 
 

none/few

0-15

 

26

0-135

 

77

 

moderate

16-75

 

47

   
 

many

>75

 

27

> 135

 

23

  1. Peritumoral infiltrate could not be reliably determined in all patients, because of the absence of invasive front in several tumor samples.